Patents by Inventor Ryan Scott STREEPER

Ryan Scott STREEPER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11312766
    Abstract: Provided herein are monoclonal antibodies (e.g., human antibodies) binding to human Growth Differentiation Factor 15 protein (hereinafter, sometimes referred to as “GDF15”), and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Grant
    Filed: April 26, 2017
    Date of Patent: April 26, 2022
    Assignee: NOVARTIS AG
    Inventors: Hong Chen, Rajiv Chopra, Seung Wan Hahm, Norio Hamamatsu, Ryan Scott Streeper, Mei Xu
  • Publication number: 20190135908
    Abstract: Provided herein are monoclonal antibodies (e.g., human antibodies) binding to human Growth Differentiation Factor 15 protein (hereinafter, sometimes referred to as “GDF15”), and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Application
    Filed: April 26, 2017
    Publication date: May 9, 2019
    Inventors: Hong CHEN, Rajiv CHOPRA, Seung Wan HAHM, Norio HAMAMATSU, Ryan Scott STREEPER, Mei XU
  • Publication number: 20170204149
    Abstract: The disclosure relates to fusion polypeptides comprising serum albumin or a functional variant thereof and GDF15 protein or a functional variant thereof and to pharmaceutical compositions that contain the fusion polypeptides, nucleic acids that encode the fusion polypeptides, methods of making the polypeptides and use of the polypeptides to decreasing appetite, decreasing body weight and treating metabolic diseases.
    Type: Application
    Filed: June 19, 2015
    Publication date: July 20, 2017
    Applicant: NOVARTIS AG
    Inventors: Rajiv CHOPRA, Norio HAMAMATSU, Ryan Scott STREEPER, Brian Edward VASH